The Enterprise Value as of December 2025 (TTM) for Theravance Biopharma, Inc. (TBPH) is 817.41M

According to Theravance Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 817.41M. This represents a change of 83.40% compared to the average of 445.70M of the last 4 quarters.

Theravance Biopharma, Inc. (TBPH) Historical Enterprise Value (quarterly & annually)

How has TBPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Theravance Biopharma, Inc. over the last ten years is 1.14B. The current 817.41M Enterprise Value has changed 7.08% with respect to the historical average. Over the past ten years (40 quarters), TBPH's Enterprise Value was at its highest in in the June 2017 quarter at 2.17B. The Enterprise Value was at its lowest in in the June 2025 quarter at 317.98M.

Theravance Biopharma, Inc. (TBPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theravance Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theravance Biopharma, Inc. (TBPH) Average Enterprise Value

How has TBPH Enterprise Value performed in the past?

The current Enterprise Value of Theravance Biopharma, Inc. (TBPH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Theravance Biopharma, Inc. (TBPH) Enterprise Value vs. Peers

How is TBPH’s Enterprise Value compared to its peers?

Theravance Biopharma, Inc.’s Enterprise Value is greater than BlackRock Technology and Private Equity Term Trust (786.63M), less than Monte Rosa Therapeutics, Inc. (1.10B), greater than Day One Biopharmaceuticals, Inc. (815.93M), less than Geron Corporation (854.51M), greater than Replimune Group, Inc. (804.93M), greater than Vir Biotechnology, Inc. (737.27M), greater than LENZ Therapeutics, Inc. (742.15M), less than ArriVent BioPharma, Inc. Common Stock (892.49M), greater than Valneva SE (684.12M), less than Tyra Biosciences, Inc. (1.09B),

Build a custom stock screener for Theravance Biopharma, Inc. (TBPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theravance Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theravance Biopharma, Inc. (TBPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theravance Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.